Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury

Nature Medicine

Volumn 2, Issue 3, 1996, Pages 293-298

  Rade, Jeffrey J ^a,c   Schulick, Andrew H ^a   Virmani, Renu ^b   Dichek, David A ^a,d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPIRUDIN; THROMBIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; CAROTID ARTERY INJURIES; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIRUDINS; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0029880254     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0396-293     Document Type: Article

References (12)

1. Fuster, V., Badimon, L., Badimon, J.J. & Chesebro, J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N. Engl. J. Med. 326, 310-318 (1992).
2. Blombäck, B. Studies on the action of thrombic enzymes on bovine fibrinogen as measured by N-terminal analysis. Arkiv. Kemi. 12, 321-335 (1958).
3. Davey, M.G. & Lüscher, E.F. Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature 216, 857-858 (1967).
4. McNamara, C.A. et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91, 94-98 (1993).
5. Markwardt, F. Hirudin as an inhibitor of thrombin. Methods Enzymol. 19, 924-932 (1970).
6. Just, M., Tripier, D. & Seiffge, D. Antithrombotic effects of recombinant hirudin in different animal models. Haemostasis 21 (Suppl. 1), 80-87 (1991).
7. Sarembock, I.J. et al. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 84, 232-243 (1991).
8. Topol, E.J. et al. Recombinant hirudin for unstable angina pectoris: A multicenter, randomized angiographic trial. Circulation 89, 1557-1566 (1994).
9. Serruys, P.W. et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N. Engl. J. Med. 333, 757-763 (1995).
10. van den Bos, A.A. et al. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation 88, 2058-2066 (1993).
11. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Ha Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 90, 1631-1637 (1994).
12. Wallace, A., Dennis, S., Hofsteenge, J. & Stone, S.R. Contribution of the N-terminal region of hirudin to its interaction with thrombin. Biochemistry 28, 10079-10084 (1989).